ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Eludril® N:Pierre Fabre Pharma AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
A01AB03 - ChlorhexidineATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A01 - Stomatological Preparations
 
A01A - Stomatological Preparations

This group comprises agents for treatment of conditions of mouth and teeth. Preparations mainly used in gingivitis, stomatitis etc. should be classified in this group.
Preparations for the treatment of throat infections, (lozenges for common cold conditions) or treatment of symptoms both in mouth and throat are classified in R02 - Throat preparations.
Preparations containing local anesthetics, see N01B - Anesthetics, local, and R02AD - Anesthetics, local.

A01AB - Antiinfectives and Antiseptics for Local Oral Treatment

This group comprises all antiinfective and antiseptic agents for the treatment of stomatitis, gingivitis etc. Products used in common minor infections of mouth and throat are classified in R02, e.g. cetylpyridinium.
Combinations of tetracycline with anti-inflammatory agents are classified at the same 5th level as plain tetracycline (A01AB13).
Other antibiotics for local use, see D - Dermatologicals.

The DDD for amphotericin in this group refers to lozenges.
The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.

A01AB03 - Chlorhexidine
DoseRoute of administrationNote
 O 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home